TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Time in target range (70-180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: K levels ≥ 4.5 as a predictor of AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Weight gain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global rank
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: KCCQ-12 SS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Symptoms of physiological discomforts during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Mayo score remission at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year P2Y12 inhibitor persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptom burden (periocular ache)
Endpoint domain: Adverse events/effects
Primary endpoint: global indices of Humphrey visual field
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for digital scanning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived difficulty of conventional impressions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: success rate of procedure sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of respiratory depression and hypoxia
Endpoint domain: Adverse events/effects
Primary endpoint: perineal pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intactness of perineum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical comfort level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time from simulated OHCA onset to AED delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PBD-related complication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PBD- or surgery-related complication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median hospital stay after surgery
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: cross‐sectional area (CSA) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PRTEE scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: total crystalloid administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: requirements for blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of the video telehealth platform
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement, communication, and interaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Normalization rates of plantar skin blood flow after walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Apoptotic neuron loss
Endpoint domain: Adverse events/effects
Primary endpoint: five-year cumulative BF rate
Endpoint domain: Mortality/survival
Primary endpoint: weekly frequency of CSBMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: abdominal symptoms score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: overall IBS severity index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: improvement in 2PD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak-to-peak SEP amplitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shortened latencies for N20, N60, and P100
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in prevalence of IPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant understanding scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Participant satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oxygen output reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of major LARS after 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EPAO total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time spent in light-intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mCSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: BSLA Response Rate (BSLA RR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median rPFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first SSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BCR::ABL1IS response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median duration of response (mDoR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interest in medicine delivery service
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Retention in treatment and remission
Endpoint domain: Mortality/survival
Primary endpoint: Total alcohol consumption (TAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of heavy drinking days (NHDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perceived effectiveness of MHWLs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Believability of MHWLs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of MHWLs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cancer-related fatigue (CRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart rate measures of stress reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in anorexia
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ILD progression (absolute decline in FVC ≥10% predicted)
Endpoint domain: Mortality/survival
Primary endpoint: Acute exacerbation of ILD
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in average VAS score for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to radiographic healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in peak O2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Triglycerides/High-Density Lipoprotein Cholesterol (TG/HDLc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: grade ≥ 3 mucositis rates
Endpoint domain: Adverse events/effects
Primary endpoint: VAS for paresthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rates on the implant and restorative levels
Endpoint domain: Mortality/survival
Primary endpoint: Overall technical complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Odds of skipping the question
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: distal hypoalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mechanical hypoesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Infarct growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: percent reduction in bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Net clinical benefit of DAPT duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CRBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: c-fos mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAED scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AQ mean score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Surgical Site Infections (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Daytime activity pattern classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSE score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PSSS score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Use of Postpartum Family Planning (PPFP)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change scores in performance and satisfaction of selected goals
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Gastric leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Axial rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of IH (Inguinal Hernia)
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative abscesses
Endpoint domain: Adverse events/effects
Primary endpoint: 30-day readmissions
Endpoint domain: Adverse events/effects
Primary endpoint: swab application reaction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of CR (Clinical Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of AL (Adverse Events)
Endpoint domain: Adverse events/effects
Primary endpoint: Severe acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: RH-PAT indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Circulating CD34+ EPCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average anastomosis time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Health-related productivity loss (HRPL)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Upper extremity motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily life ability score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: stool sIgA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Satisfaction with clinical care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: win ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean composite signs severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confidence in head and neck anatomy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean glucose excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean peak glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time to peak glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: dose errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in QLF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical worsening within 11 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPG AUC0-3 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: non-cavitated caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: cavitated caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Complete response (CR) rates for vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with no nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS-PI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days with constipation
Endpoint domain: Adverse events/effects
Primary endpoint: Days with upset stomach
Endpoint domain: Adverse events/effects
Primary endpoint: Segmentation accuracy (DSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Segmentation errors (qualitative evaluation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive and receptive language development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Socioemotional development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reaching HbA1c <7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of documented symptomatic hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Mean root length of MSP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corrected serum calcium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: KOOS-Total improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D-5L index scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Subjective patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-treatment pulmonary artery systolic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total percent body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: persistent nausea incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in insulin AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: IGF-1 SDS treatment difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in GH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with ≥1 acromegaly symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients on spironolactone at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incident NAFLD risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach T6 dermatome sensory level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diastolic blood pressure (DBP) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in scores on RIPLS, IEPS and TSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of lateral ankle sprains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time loss per injury
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: minor harms reported
Endpoint domain: Adverse events/effects
Primary endpoint: Ovarian cancer survival
Endpoint domain: Mortality/survival
Primary endpoint: proportion of patients with sequelae
Endpoint domain: Adverse events/effects
Primary endpoint: decline in cerebrospinal fluid mononuclear cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acceptability of ODF compared to syrup
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance with scheduled content
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Complete response at 30, 60, and 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial response of GVHD achieved faster
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of uterine preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month recognition memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: No show rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of psychology visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Area under the concentration-time curve (AUC) for paracetamol 0 to 5 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for TPK
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of EEG recording
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mutual satisfaction of parents and technicians
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Secondary procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Healing with deformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Isometric strength of Knee extensor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Worst pain post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Modified Falls Efficacy Scale (MFES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multi‐Directional Reach Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to ALT normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Image quality of CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image quality of PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new onset depression/anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in Viral Load (VL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstrual cycle changes/uterine bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: duration of vasopressor support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluid balance within the initial 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days goal achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stable LD and CD exposures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NPS scores indicating user satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensitivity of CA19-9 for pancreatic cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early surgical morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Late surgical morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of overall morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: self-management skill (tracking health)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cough frequency and severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS-Back score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in symptoms (itching, pain, burning, dyspareunia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in inflammatory cell types
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in clinical signs (cervical erosions, fissures, stenosis, leukoderma)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resumption of alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean postoperative subjective IKDC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: side‐to‐side percentage deficits in isokinetic hamstring strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean reduction in log10 VL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical Rating Scale pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reclassification rate at 12-month random biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mothers' knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: primary outcome event
Endpoint domain: Mortality/survival
Primary endpoint: biochemically-validated smoking abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes